BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdel-Aziz AA, El-Azab AS, Bua S, Nocentini A, Abu El-Enin MA, Alanazi MM, AlSaif NA, Hefnawy MM, Supuran CT. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives. Bioorg Chem 2019;87:425-31. [PMID: 30921744 DOI: 10.1016/j.bioorg.2019.03.052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Alkahtani HM, Abdalla AN, Obaidullah AJ, Alanazi MM, Almehizia AA, Alanazi MG, Ahmed AY, Alwassil OI, Darwish HW, Abdel-aziz AA, El-azab AS. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Bioorganic Chemistry 2020;95:103461. [DOI: 10.1016/j.bioorg.2019.103461] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
2 Sağlık BN, Osmaniye D, Çevik UA, Levent S, Çavuşoğlu BK, Büyükemir O, Nezir D, Karaduman AB, Özkay Y, Koparal AS, Beydemir Ş, Kaplancıklı ZA. Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate. Eur J Med Chem 2020;198:112392. [PMID: 32388113 DOI: 10.1016/j.ejmech.2020.112392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Moi D, Nocentini A, Deplano A, Balboni G, Supuran CT, Onnis V. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation. Eur J Med Chem 2019;182:111638. [PMID: 31472471 DOI: 10.1016/j.ejmech.2019.111638] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
4 Singh A, Malhotra D, Singh K, Chadha R, Bedi PMS. Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes. Journal of Molecular Structure 2022;1266:133479. [DOI: 10.1016/j.molstruc.2022.133479] [Reference Citation Analysis]
5 Kumar S, Rulhania S, Jaswal S, Monga V. Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. Eur J Med Chem 2021;209:112923. [PMID: 33121862 DOI: 10.1016/j.ejmech.2020.112923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V. Recent advancements in the development of bioactive pyrazoline derivatives. Eur J Med Chem 2020;205:112666. [PMID: 32795767 DOI: 10.1016/j.ejmech.2020.112666] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Kumar A, Siwach K, Supuran CT, Sharma PK. A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors. Bioorganic Chemistry 2022;126:105920. [DOI: 10.1016/j.bioorg.2022.105920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 El-Azab AS, Abdel-Aziz AA, Ahmed HEA, Bua S, Nocentini A, AlSaif NA, Obaidullah AJ, Hefnawy MM, Supuran CT. Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2020;35:598-609. [PMID: 32009479 DOI: 10.1080/14756366.2020.1722121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, AlSaif NA, Alanazi MM, El-Gendy MA, Ahmed HEA, Supuran CT. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem 2020;35:733-43. [PMID: 32189526 DOI: 10.1080/14756366.2020.1742117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hargunani P, Tadge N, Ceruso M, Leitans J, Kazaks A, Tars K, Gratteri P, Supuran CT, Nocentini A, Toraskar MP. Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide Derivatives Bearing a Sulfonamide Moiety Show Single-digit Nanomolar-to-Subnanomolar Inhibition Constants against the Tumor-associated Human Carbonic Anhydrases IX and XII. Int J Mol Sci 2020;21:E2621. [PMID: 32283813 DOI: 10.3390/ijms21072621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abdel-Aziz AA, El-Azab AS, AlSaif NA, Alanazi MM, El-Gendy MA, Obaidullah AJ, Alkahtani HM, Almehizia AA, Al-Suwaidan IA. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study. J Enzyme Inhib Med Chem 2020;35:610-21. [PMID: 32013633 DOI: 10.1080/14756366.2020.1722120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Yamali C, Gul HI, Kazaz C, Levent S, Gulcin I. Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes. Bioorganic Chemistry 2020;96:103627. [DOI: 10.1016/j.bioorg.2020.103627] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
13 Al-Sanea MM, Chilingaryan G, Abelyan N, Arakelov G, Sahakyan H, Arakelov VG, Nazaryan K, Hussein S, Alazmi GM, Alsharari HE, Al-Faraj WM, Alruwaili FS, Albilasi NQ, Alsharari TS, Alsaleh AAS, Alazmi TM, Almalki AH, Alotaibi NH, Abdelgawad MA. Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery. Sci Rep 2021;11:15516. [PMID: 34330958 DOI: 10.1038/s41598-021-94809-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Sever B, Türkeş C, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Arch Pharm (Weinheim) 2021;:e2100294. [PMID: 34569655 DOI: 10.1002/ardp.202100294] [Reference Citation Analysis]
15 El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, AlSaif NA, Almehizia AA, Alanazi MM, Hefnawy MM, Supuran CT. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment. Eur J Med Chem 2019;181:111573. [PMID: 31394463 DOI: 10.1016/j.ejmech.2019.111573] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
16 El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, Alanazi MM, AlSaif NA, Al-Suwaidan IA, Hefnawy MM, Supuran CT. Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds. Bioorg Chem 2019;92:103225. [PMID: 31493707 DOI: 10.1016/j.bioorg.2019.103225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]